The IBM blood cell separator and blood cell processor: A personal perspective

1988 ◽  
Vol 4 (4) ◽  
pp. 171-182 ◽  
Author(s):  
Alan L. Jones
Keyword(s):  
Blood Cell ◽  
Personal Perspective ◽  
Cell Processor ◽  
Cell Separator ◽  
Blood Cell Separator

Collection of platelets and peripheral progenitor cells with the Fresenius AS.TEC 204 blood cell separator

1997 ◽  
Vol 12 (3) ◽  
pp. 126-129 ◽  
Author(s):  
Rainer Moog ◽  
Mauro Valbonesi ◽  
Paolo Carlier ◽  
Norbert Müller ◽  
Frank Eisenbeisz ◽  
...  
Keyword(s):  
Blood Cell ◽  
Progenitor Cells ◽  
Cell Separator ◽  
Blood Cell Separator

Separation of Mononuclear Bone Marrow Cells using the Cobe 2997 Blood Cell Separator

Vox Sanguinis ◽  
1988 ◽  
Vol 55 (3) ◽  
pp. 133-138
Author(s):  
A. Faradji ◽  
G. Andreu ◽  
C. Pillier-Loriette ◽  
A. Bohbot ◽  
A. Nicod ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Blood Cell ◽  
Bone Marrow Cells ◽  
Cell Separator ◽  
Blood Cell Separator ◽  
Mononuclear Bone Marrow Cells ◽  
Marrow Cells

Evaluation of Two Different Protocols for Peripheral Blood Stem Cell Collection with the Fresenius AS 104 Blood Cell Separator

Vox Sanguinis ◽  
1997 ◽  
Vol 73 (4) ◽  
pp. 230-236
Author(s):  
Bruno Bizzi ◽  
Giacomo Menichella ◽  
Marco Lai ◽  
Luca Pierelli ◽  
Mariangela Vittori ◽  
...  
Keyword(s):  
Stem Cell ◽  
Blood Cell ◽  
Peripheral Blood ◽  
Peripheral Blood Stem Cell ◽  
Blood Stem Cell ◽  
Cell Separator ◽  
Blood Cell Separator ◽  
Stem Cell Collection

Evaluation of Platelet Concentrates with the New Dideco Blood Cell Separator: Excel

1993 ◽  
Vol 16 (5_suppl) ◽  
pp. 130-134 ◽  
Author(s):  
F. Schooneman
Keyword(s):  
Blood Cell ◽  
Platelet Activation ◽  
Complement Activation ◽  
The Other ◽  
Platelet Concentrates ◽  
Cell Separator ◽  
Good Compromise ◽  
Blood Cell Separator ◽  
The Future

The Excel Cell Separator produced by Dideco represents a good compromise between automation and Platelet efficiency. Platelet activation is a phenomenon that we can find with the concentrates of all cell separators. Although, the complement activation of Excel is extremely lower in comparison with the same data obtained using all the other cell separators, the 5-day storage is acceptable. It will be important to research the bacteriological controls. Like the pH of the platelet bags, because in certain cases it was too low. For the future it will be interesting to study the possibility to predict the quantity of platelets collected having a system that is adaptable with the donor parameters.

scholarly journals A controlled comparison of the efficacy of hetastarch and pentastarch in granulocyte collections by centrifugal leukapheresis

Blood ◽  
1995 ◽  
Vol 86 (12) ◽  
pp. 4662-4666 ◽  
Author(s):  
JH Lee ◽  
SF Leitman ◽  
HG Klein
Keyword(s):  
Molecular Weight ◽  
Blood Cell ◽  
Red Blood Cell ◽  
Potential Benefit ◽  
Collection Efficiency ◽  
Low Molecular Weight ◽  
Cell Separator ◽  
Two Agents ◽  
Blood Cell Separator ◽  
Rapid Elimination

Compared with hetastarch (HS), the low molecular weight analog pentastarch (PS) has been reported to be equally effective for granulocyte collection by centrifugal leukapheresis, to result in fewer adverse donor reactions (ADR), and to have a more rapid elimination profile. We prospectively compared the granulocyte collection efficiency (GCE), granulocyte yield, and ADR in 72 randomly paired granulocytapheresis procedures from 36 volunteer donors using the model CS-3000 Plus Blood Cell Separator (CS) and either PS or HS as the sedimenting agent. Paired collections from each donor allowed us to compare the two agents directly while controlling for intrinsic donor differences. In 33 of 36 (92%) donors, HS procedures were significantly more efficient than PS procedures (P < .001). As an average, HS collections yielded 2.3 +/- 0.67 x 10(10) granulocytes at 58% +/- 8.8% GCE, whereas PS procedures resulted in 1.4 +/- 0.76 x 10(10) granulocytes at 33% +/- 15% GCE. No starch-induced ADR were seen with either agent. For granulocyte harvests using the CS, (1) in most donors, using HS as the red blood cell sedimenting agent during centrifugal leukapheresis results in significantly higher (nearly twofold) GCE and larger granulocyte yields in comparison with using PS, (2) ADR were not observed with either agent, and (3) the potential benefit of more rapid PS elimination should be balanced against significantly lower granulocyte yields.

Therapeutic Cytapheresis Using the Fenwal CS-3000 Blood Cell Separator

Vox Sanguinis ◽  
1985 ◽  
Vol 48 (4) ◽  
pp. 193-200
Author(s):  
Theresa A. Steeper ◽  
Judith A. Smith ◽  
Jeffrey McCullough
Keyword(s):  
Blood Cell ◽  
Cell Separator ◽  
Blood Cell Separator
Sign in / Sign up

Export Citation Format

Share Document